Anti Tumor Activity Of Selinexor (KPT-330), A First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) XPO1/CRM1 Antagonist In Patients (pts) With Relapsed / Refractory Multiple Myeloma (MM) Or Waldenstrom's Macroglobulinemia (WM) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Chen, Christine I
  • Gutierrez, Martin
  • Brown, Peter de Nully
  • Gabrail, Nashat
  • Baz, Rachid
  • Reece, Donna E
  • Savona, Michael
  • Trudel, Suzanne
  • Siegel, David S
  • Mau-Sorensen, Morten
  • Kuruvilla, John
  • Byrd, John C
  • Shacham, Sharon
  • Rashal, Tami
  • Yau, Cindy YF
  • McCauley, Dilara
  • Landesman, Yosef
  • Klebanov, Boris
  • Pond, Gregory
  • Oza, Amit M
  • Kauffman, Michael
  • Mirza, Mansoor R

publication date

  • November 15, 2013

published in